Outpace Bio to present new data on programmed CAR T cell candidate OPB-101 at the 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 05, 2024 09:00 ET
|
Outpace Bio
Outpace Bio at SITC 2024: AI-powered OPB-101 CAR T cells show lasting functional persistence, enhanced anti-tumor activity, & stem central memory phenotype
Outpace Bio Announces $144M Oversubscribed Series B Financing to Advance AI-powered Cell Therapies into Clinical Development
August 01, 2024 09:00 ET
|
Outpace Bio
Seattle, WA, Aug. 01, 2024 (GLOBE NEWSWIRE) -- – Financing syndicate led by RA Capital Management with significant support from a world-class group of existing and new healthcare investors –...
Outpace Bio Announces Multiple Presentations at the 2024 American Association of Cancer Research (AACR) Annual Meeting
April 04, 2024 07:00 ET
|
Outpace Bio
Seattle, WA, April 04, 2024 (GLOBE NEWSWIRE) -- Outpace Bio, a cell therapy company that is solving the major barriers to curing solid tumors with unrivaled AI-powered protein design, today...
Outpace Bio to Present New Data on Tumor-restricted IL-12 Designed Leveraging OutSmart Technology to Enhance Solid Tumor T Cell Therapies at SITC 2023
October 31, 2023 09:00 ET
|
Outpace Bio
Seattle, WA, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a cell therapy company that is solving the major barriers to curing solid tumors with AI-powered protein design, today announced it will...
Outpace Bio Expands Seattle Presence with Cell Therapy Research Hub & Collaborations with Leading Experts in Protein Design & Cancer Immunotherapy
May 22, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 22, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced the...
Outpace Bio to Present New Data on OutSmart™ IL-2/15, a CAR T Cell-Produced Designed Cytokine with Tumor-Localized Immune Cell Activity, at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 18, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 18, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced it will...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Announces Presentation at the 2023 Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
May 09, 2023 09:00 ET
|
Outpace Bio
Seattle, WA, May 09, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies with curative potential, today announced that an...
Outpace Bio, a Leader in Protein Design for Cell Therapy, Strengthens Executive Leadership Team with Key Appointments
May 04, 2023 08:00 ET
|
Outpace Bio
Seattle, WA, May 04, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced two key leadership appointments....
Outpace Bio, a Leader in Protein Design & Cell Engineering, Adds Bahija Jallal to Board of Directors
March 23, 2023 09:00 ET
|
Outpace Bio
Seattle, WA, March 23, 2023 (GLOBE NEWSWIRE) -- Outpace Bio, a company using protein design and cell engineering to create advanced cell therapies, today announced that Dr. Bahija Jallal has joined...